Results from the German Chronic Kidney Disease (GCKD) study support association of relative telomere length with mortality in a large cohort of patients with moderate chronic kidney disease
Federica Fazzini(Innsbruck Medical University), Claudia Sommerer(Heidelberg University), Erna Mitsch, Rita Zitzmann, Ursula Reinhard, Heike Meiselbach, Markus P. Schneider, Dinah Becker-Grosspitsch, Simone Meder, Seema Baid‐Agrawal(Sahlgrenska University Hospital), Ulla T. Schultheiß(Pediatrics and Genetics), Susanne Avendaño(Ludwig-Maximilians-Universität München), Kerstin Theisen, Thomas Dienemann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Birgit Hausknecht, Lukas Forer(Innsbruck Medical University), Matthias Schmid(Zimmer Biomet (Netherlands)), Christoph Wanner(Universitätsklinikum Würzburg), Julia Raschenberger(Innsbruck Medical University), Elke Schäeffner, Arif B. Ekici(University Medical Center Groningen), Gerd Walz(University of Freiburg), Fruzsina Kotsis, Hans‐Ulrich Prokosch(Friedrich-Alexander-Universität Erlangen-Nürnberg), Martin Zeier(Heidelberg University), Inga Steinbrenner(University of Freiburg), Hansi Weißensteiner(Innsbruck Medical University), Claudia Lamina(Innsbruck Medical University), Kai‐Uwe Eckardt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Georg Schlieper(RWTH Aachen University), Anna Köttgen(University of Freiburg), Thomas Ganslandt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Florian Kronenberg(Innsbruck Medical University), Jan Menne, Sabine Ernst(Royal Brompton & Harefield NHS Foundation Trust), Anke Weigel, André Reis, Andreas Beck, Nicole Beaujean, Barbara Bärthlein, Sebastian Schönherr(University Hospital Leipzig), Turgay Saritas, Hermann Haller(Mount Desert Island Biological Laboratory), Jürgen Floege(RWTH Aachen University)
Cited by 38
Related Papers
Next-generation genotype imputation service and methods
|Nature Genetics|2016|4.5k
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2005|3.9k
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k